Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 2 (2005), Issue 7 (July)

1. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren's syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria.
   Autoimmun Rev, 4(5): 276-81. [Abstract] [Full-text]
2. Radiosynoviorthesis in osteoarthritis and other disorders with concomitant synovitis in comparison to rheumatoid arthritis.
   Cancer Biother Radiopharm, 20(3): 349-55. [Abstract] [Full-text]
3. Effects of radiosynovectomy with p-32 colloid therapy in hemophilia and rheumatoid arthritis.
   Cancer Biother Radiopharm, 20(3): 344-8. [Abstract] [Full-text]
4. Proteomic: new advances in the diagnosis of rheumatoid arthritis.
   Clin Chim Acta, 357(2): 219-25. [Abstract] [Full-text]
5. Total knee arthroplasty in juvenile rheumatoid arthritis.
   J Bone Joint Surg Am, 87(7): 1510-4. [Abstract] [Full-text]
6. Interleukin 12 (IL12B) and interleukin 12 receptor (IL12RB1) gene polymorphisms in rheumatoid arthritis.
   Hum Immunol, 66(6): 710-5. [Abstract] [Full-text]
7. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis.
   Lancet, 366(9479): 50-6. [Abstract] [Full-text]
8. Variability in the traditional Chinese medicine (TCM) diagnoses and herbal prescriptions provided by three TCM practitioners for 40 patients with rheumatoid arthritis.
   J Altern Complement Med, 11(3): 415-21. [Abstract] [Full-text]
9. Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts.
   Arthritis Rheum, 52(7): 2010-4. [Abstract] [Full-text]
10. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
    Arthritis Rheum, 52(7): 1993-8. [Abstract] [Full-text]
11. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis.
    Arthritis Rheum, 52(7): 2092-102. [Abstract] [Full-text]
12. Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis.
    Arthritis Rheum, 52(7): 2003-9. [Abstract] [Full-text]
13. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.
    Arthritis Rheum, 52(7): 1986-92. [Abstract] [Full-text]
14. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
    Arthritis Rheum, 52(7): 2109-19. [Abstract] [Full-text]
15. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy.
    Arthritis Rheum, 52(7): 2103-8. [Abstract] [Full-text]
16. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
    Arthritis Rheum, 52(7): 2192-201. [Abstract] [Full-text]
17. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis.
    Arthritis Rheum, 52(7): 1999-2002. [Abstract] [Full-text]
18. Regulation of p38 MAP kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis.
    Clin Immunol, 116(2): 101-7. [Abstract] [Full-text]
19. Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis.
    Clin Exp Immunol, 141(2): 372-80. [Abstract] [Full-text]
20. Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts.
    Clin Exp Immunol, 141(2): 363-71. [Abstract] [Full-text]
21. Rat bite fever mimicking rheumatoid arthritis.
    Scand J Infect Dis, 37(6): 532-3. [Abstract] [Full-text]
22. Capitellocondylar total elbow replacement in late-stage rheumatoid arthritis.
    J Shoulder Elbow Surg, 14(4): 414-20. [Abstract] [Full-text]
23. Women with early rheumatoid arthritis are referred later than men.
    Ann Rheum Dis, 64(8): 1227-8. [Abstract] [Full-text]
24. Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis.
    Ann Rheum Dis, 64(8): 1224-6. [Abstract] [Full-text]
25. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.
    Ann Rheum Dis, 64(8): 1126-31. [Abstract] [Full-text]
26. Autoimmunity and coxsackievirus infection in primary Sjogren's syndrome.
    Ann N Y Acad Sci, 1050: 389-96. [Abstract] [Full-text]
27. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Ann N Y Acad Sci, 1050: 295-303. [Abstract] [Full-text]
28. A deiminated viral peptide to detect antibodies in rheumatoid arthritis.
    Ann N Y Acad Sci, 1050: 243-9. [Abstract] [Full-text]
29. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
    Ann N Y Acad Sci, 1050: 210-6. [Abstract] [Full-text]
30. Response criteria for rheumatoid arthritis in clinical practice: how useful are they?
    Ann Rheum Dis, 64(8): 1186-9. [Abstract] [Full-text]
31. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis.
    Ann Rheum Dis, 64(8): 1195-8. [Abstract] [Full-text]
32. Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial.
    Ann Rheum Dis, 64(8): 1174-9. [Abstract] [Full-text]
33. Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis.
    Ann Rheum Dis, 64(8): 1190-4. [Abstract] [Full-text]
34. Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study.
    Ann Rheum Dis, 64(8): 1180-5. [Abstract] [Full-text]
35. Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences.
    Ann Rheum Dis, 64(8): 1141-4. [Abstract] [Full-text]
36. Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent.
    Ann Rheum Dis, 64(8): 1220-3. [Abstract] [Full-text]
37. No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years.
    Arch Dermatol, 141(7): 861-4. [Abstract] [Full-text]
38. TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis.
    Clin Sci (Lond), 109(2): 135-42. [Abstract] [Full-text]
39. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
    Rheumatology (Oxford), 44(8): 1021-5. [Abstract] [Full-text]
40. Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure.
    Rheumatology (Oxford), 44(8): 1026-31. [Abstract] [Full-text]
41. Etanercept and uveitis in patients with juvenile idiopathic arthritis.
    Rheumatology (Oxford), 44(8): 1008-11. [Abstract] [Full-text]
42. Outcome following onset of juvenile idiopathic inflammatory arthritis: I. frequency of different outcomes.
    Rheumatology (Oxford), 44(8): 995-1001. [Abstract] [Full-text]
43. Outcome following onset of juvenile idiopathic inflammatory arthritis: II. predictors of outcome in juvenile arthritis.
    Rheumatology (Oxford), 44(8): 1002-7. [Abstract] [Full-text]
44. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
    Clin Sci (Lond), 109(2): 171-6. [Abstract] [Full-text]
45. Recent-onset rheumatoid arthritis: a 1-year observational study of correlations between health-related quality of life and clinical/laboratory data.
    J Rehabil Med, 37(3): 159-65. [Abstract] [Full-text]
46. Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab.
    Autoimmunity, 38(2): 155-60. [Abstract] [Full-text]
47. Sjögren's syndrome.
    Lancet, 366(9482): 321-31. [Abstract] [Full-text]
48. Intra- and inter-rater reliability of the anterior atlantodental interval measurement from conventional lateral view flexion/extension radiographs.
    Man Ther, 10(3): 219-23. [Abstract] [Full-text]
49. Infliximab continuation rates in patients with rheumatoid arthritis in everyday practice.
    Joint Bone Spine, 72(4): 309-12. [Abstract] [Full-text]
50. Improvement of the clinical outcome in Ankylosing spondylitis by balneotherapy.
    Joint Bone Spine, 72(4): 303-8. [Abstract] [Full-text]
51. MR imaging findings in hands in early rheumatoid arthritis: comparison with those in systemic lupus erythematosus and primary Sjögren syndrome.
    Radiology, 236(2): 593-600. [Abstract] [Full-text]
52. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.
    Arch Intern Med, 165(14): 1624-9. [Abstract] [Full-text]
53. Long-term results of the uncemented low contact stress total knee replacement in patients with rheumatoid arthritis.
    J Bone Joint Surg Br, 87(8): 1077-80. [Abstract] [Full-text]
54. Efficacy and tolerance of atrisin in degenerative and inflammatory joint disorders.
    Phytother Res, 19(4): 365-8. [Abstract] [Full-text]
55. Physiologic response of the six-minute walk test in children with juvenile idiopathic arthritis.
    Arthritis Rheum, 53(3): 351-6. [Abstract] [Full-text]
56. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
    Arthritis Rheum, 53(3): 320-7. [Abstract] [Full-text]
57. Development of a foot impact scale for rheumatoid arthritis.
    Arthritis Rheum, 53(3): 418-22. [Abstract] [Full-text]
58. Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis.
    Arthritis Rheum, 53(3): 410-7. [Abstract] [Full-text]
59. Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?
    Arthritis Rheum, 52(6): 1711-20. [Abstract] [Full-text]
60. Juvenile-onset ankylosing spondylitis is associated with worse functional outcomes than adult-onset ankylosing spondylitis.
    Arthritis Rheum, 53(3): 445-51. [Abstract] [Full-text]
61. Impact of managed care on the use of biologic agents for rheumatoid arthritis.
    Arthritis Rheum, 53(3): 423-30. [Abstract] [Full-text]
62. Validating the International Classification of Functioning, Disability and Health Comprehensive Core Set for Rheumatoid Arthritis from the patient perspective: a qualitative study.
    Arthritis Rheum, 53(3): 431-9. [Abstract] [Full-text]
63. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene.
    Arthritis Rheum, 52(6): 1694-9. [Abstract] [Full-text]
64. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency.
    Arthritis Rheum, 52(6): 1721-9. [Abstract] [Full-text]
65. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome.
    Arthritis Rheum, 52(6): 1773-84. [Abstract] [Full-text]
66. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial.
    Arthritis Rheum, 52(6): 1756-65. [Abstract] [Full-text]
67. Class II major histocompatibility complex-peptide tetramer staining in relation to functional avidity and T cell receptor diversity in the mouse CD4(+) T cell response to a rheumatoid arthritis-associated antigen.
    Arthritis Rheum, 52(6): 1885-96. [Abstract] [Full-text]
68. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Arthritis Rheum, 52(6): 1794-803. [Abstract] [Full-text]
69. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages.
    Arthritis Rheum, 52(6): 1700-10. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.